S
Swapnil Potdar
Researcher at University of Helsinki
Publications - 33
Citations - 371
Swapnil Potdar is an academic researcher from University of Helsinki. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 7, co-authored 21 publications receiving 162 citations.
Papers
More filters
Journal ArticleDOI
Prediction of drug combination effects with a minimal set of experiments.
Aleksandr Ianevski,Anil K. Giri,Prson Gautam,Alexander Kononov,Swapnil Potdar,Jani Saarela,Krister Wennerberg,Krister Wennerberg,Tero Aittokallio,Tero Aittokallio,Tero Aittokallio +10 more
TL;DR: DECREASE, an efficient machine learning model that requires only a limited set of pairwise dose–response measurements for the accurate prediction of synergistic and antagonistic drug combinations, is implemented.
Journal ArticleDOI
Breeze: an integrated quality control and data analysis application for high-throughput drug screening
Swapnil Potdar,Aleksandr Ianevski,Aleksandr Ianevski,John Patrick Mpindi,Dmitrii Bychkov,Clément Fiere,Philipp Ianevski,Bhagwan Yadav,Krister Wennerberg,Krister Wennerberg,Tero Aittokallio,Tero Aittokallio,Tero Aittokallio,Olli Kallioniemi,Olli Kallioniemi,Jani Saarela,Päivi Östling,Päivi Östling +17 more
TL;DR: The Breeze application provides a complete solution for data quality assessment, dose–response curve fitting and quantification of the drug responses along with interactive visualization of the results.
Journal ArticleDOI
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Erlend Skaga,Erlend Skaga,Evgeny Kulesskiy,Artem Fayzullin,Artem Fayzullin,Cecilie Sandberg,Swapnil Potdar,Aija Kyttälä,Iver A. Langmoen,Iver A. Langmoen,Aki Laakso,Emília Gaál-Paavola,Markus Perola,Markus Perola,Krister Wennerberg,Einar O. Vik-Mo,Einar O. Vik-Mo +16 more
TL;DR: This study demonstrates that patient-derived and treatment-naïve glioblastoma stem cells cultures maintain patient-specific traits and display intertumoral heterogeneity in drug sensitivity to anticancer drugs.
Journal ArticleDOI
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors
Katja Kaipio,Ping Chen,Pia Roering,Kaisa Huhtinen,Piia Mikkonen,Päivi Östling,Päivi Östling,Laura Lehtinen,Naziha Mansuri,Taina Korpela,Swapnil Potdar,Johanna Hynninen,Annika Auranen,Seija Grénman,Krister Wennerberg,Krister Wennerberg,Sampsa Hautaniemi,Olli Carpén,Olli Carpén +18 more
TL;DR: Stemness markers in HGSC are associated with a decreased response to conventional chemotherapy and reduced survival if expressed by treatment‐naive tumours, and EGFR, mTOR‐PI3K and aurora kinase inhibitors are candidates for targeting this cell population.
Journal ArticleDOI
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.
Bertha Brodin,Krister Wennerberg,Krister Wennerberg,Elisabet Lidbrink,Otte Brosjö,Swapnil Potdar,Jennifer N. Wilson,Limin Ma,Lotte Moens,Asle C. Hesla,Edvin Porovic,Edvin Bernhardsson,Antroula Papakonstantinou,Antroula Papakonstantinou,Henrik C. F. Bauer,Panagiotis Tsagkozis,Panagiotis Tsagkozis,Karin von Sivers,Johan Wejde,Päivi Östling,Olli Kallioniemi,Christina Linder Stragliotto +21 more
TL;DR: The results show that patient-derived Sarcoma cells cultured in vitro are relevant and practical models for genotypic and phenotypic screens aiming to identify efficient drugs to treat sarcoma patients with poor treatment options.